💥Join UPSC 2027,2028 Mentorship (July Batch) + XFactor Notes & Microthemes PDF
Talk to Mentor

Civilsdaily

Login

Subject: Social Justice

  • The road to a healthy democracy

    Role of Patients in Strengthening Indian HealthCare System

    Central Idea:

    Prathap C. Reddy, founder and chairman of Apollo Hospitals Group, advocates for India’s transformation into a developed nation by 2047, emphasizing the crucial role of healthcare in this vision. He highlights India’s demographic advantage, technological innovations in preventive healthcare, and the potential for India to lead the world in healthcare delivery and medical value travel.

    Key Highlights:

    • India’s demographic dividend, with a young population, presents a significant opportunity for development.
    • The importance of prioritizing preventive healthcare to address the growing burden of chronic diseases like diabetes, cardiovascular diseases, and cancer.
    • Technological advancements, including AI and machine learning, are revolutionizing preventive healthcare by enabling early detection and personalized prevention plans.
    • India’s healthcare sector is undergoing transformation, focusing on patient-centered care, expanded access, and quality improvement.
    • India’s healthcare infrastructure and clinical talent have gained global recognition, making it a preferred destination for medical value travel, particularly in specialized treatments like oncology, cardiology, and robotic surgeries.

    Key Challenges:

    • Addressing the increasing burden of chronic diseases and lifestyle-related health issues.
    • Ensuring equitable access to preventive healthcare tools and services across all segments of the population.
    • Scaling up healthcare infrastructure and workforce to meet the growing demand, especially in rural areas.
    • Overcoming barriers to the adoption of AI-driven healthcare solutions, including data privacy concerns and regulatory challenges.
    • Balancing the need for affordable healthcare with maintaining high-quality standards in a cost-effective manner.

    Key Terms:

    • Demographic dividend
    • Preventive healthcare
    • Chronic diseases
    • Artificial Intelligence (AI)
    • Medical value travel
    • Patient-centered care
    • Healthcare infrastructure
    • Non-communicable diseases (NCDs)

    Key Phrases:

    • “Viksit Bharat” (Developed India)
    • “Health equity for all”
    • “Clinical excellence and prowess”
    • “Patient at the absolute centre”
    • “Medical value travel hub”
    • “AI-driven healthcare solutions”

    Key Quotes:

    • “India’s healthcare sector is at the cusp of transformation, potentially giving rise to a new healthcare model for the world to follow.”
    • “Preventive healthcare has touched new possibilities, empowering individuals to take control of their own health.”
    • “India stands at a pivotal moment in its healthcare journey.”
    • “Every individual and institution in the country should resolve to make India’s progress their priority.”

    Key Statements:

    • India’s demographic dividend offers a unique opportunity for development, but the health of the population is crucial for maximizing this potential.
    • Technological innovations in healthcare, including AI, have the potential to revolutionize preventive care and improve health outcomes.
    • India’s healthcare sector has gained global recognition for its clinical excellence, infrastructure, and affordability, positioning it as a leader in medical value travel.

    Key Examples and References:

    • Success of Apollo Hospitals Group in providing high-quality healthcare services and driving medical tourism in India.
    • Impact of technological interventions in preventive healthcare, such as AI-driven risk prediction and personalized prevention plans.
    • Growth of medical value travel industry in India, attracting patients from around the world for specialized treatments at lower costs.

    Key Facts and Data:

    • India’s population exceeds 1.4 billion, with a median age of 29 years, presenting a significant demographic dividend.
    • India has over 101 million diabetics and 136 million prediabetics, making it the diabetes capital of the world.
    • Cardiovascular diseases are the leading cause of mortality in India, and cancer incidence is projected to rise by 57.5% by 2040.
    • India’s healthcare costs are approximately one-tenth of the global average, making it an attractive destination for medical value travel.

    Critical Analysis:

    • While the article emphasizes the potential of technological innovations and medical value travel in transforming India’s healthcare sector, it’s essential to ensure that these developments benefit all segments of the population, particularly those in rural and underserved areas.
    • The challenge of addressing the growing burden of chronic diseases requires a comprehensive approach, including not only preventive measures but also effective management and treatment strategies.
    • Balancing affordability with quality in healthcare delivery is crucial to maintain India’s competitiveness in medical value travel while ensuring that patients receive optimal care.

    Way Forward:

    • Prioritize investments in preventive healthcare, leveraging technology to empower individuals to manage their health effectively.
    • Expand access to healthcare services, especially in rural and underserved areas, through innovative delivery models and infrastructure development.
    • Foster collaboration between public and private sectors to drive healthcare innovation and address key challenges in the sector.
    • Focus on capacity building and skill development to ensure a competent healthcare workforce capable of delivering high-quality care across all settings.
    • Advocate for policies that promote affordability, accessibility, and quality in healthcare delivery, ensuring that India’s healthcare system remains inclusive and sustainable.

  • A rising tide lifts all boats

    BJP on X: "India emerges as the fastest growing economy of the world in IMF report with growth rate of 7.4%. https://t.co/Sta44gkaZI" / X

    Central Idea:

    India has experienced a significant economic transformation, becoming the world’s fastest-growing economy. The Interim Budget reflects this progress, emphasizing preventive healthcare, innovation, and medical value travel. The private sector’s rising role is crucial for economic development and improving the overall quality of life.

    Key Highlights:

    • India’s rapid economic growth, outpacing the global average.
    • Successful space program and adept management of renewable and non-renewable energy.
    • Interim Budget aligns with the aspirations of a new India, emphasizing opportunities.
    • Focus on preventive healthcare, particularly the promotion of HPV vaccination.
    • Maternal and child health prioritized to enhance women’s participation in the workforce.
    • Commitment to innovation with a ₹1 lakh crore corpus for research and technology.
    • Medical value travel’s rising prominence, making India a global healthcare destination.
    • Private sector’s significant role in economic growth and shaping the future.

    Key Challenges:

    • Ensuring sustained economic growth amidst global uncertainties.
    • Scaling up preventive healthcare initiatives to cover various diseases.
    • Balancing budget allocations to address healthcare needs adequately.
    • Overcoming infrastructure challenges for medical value travel.
    • Ensuring inclusive growth and managing disparities in economic development.

    Key Terms:

    • HPV Vaccination: Human Papillomavirus vaccination to prevent cervical cancer.
    • Medical Value Travel: Tourism driven by healthcare services.
    • Innovation Revolution: Emphasizing technology and research for development.
    • Interim Budget: A temporary budget presented in the middle of a fiscal year.

    Key Phrases:

    • “Buoyancy of metrics and spirit.”
    • “Innovation as a key pillar of development.”
    • “Medical value travel transforming the landscape.”
    • “Private sector rising beyond expectations.”

    Key Quotes:

    • “No country can afford it if its citizens fall ill.”
    • “Innovation has the potential to create a significant impact at scale.”
    • “India will truly be limitless if we continue to work together.”

    Anecdotes:

    • Reference to Aragonda in Andhra Pradesh, a village where HPV vaccination is being promoted.
    • Mention of ‘Heal in India’ transforming the healthcare landscape.

    Key Statements:

    • “India’s space program has won the admiration of the world.”
    • “Preventive health is crucial for the overall well-being of the nation.”
    • “The private sector plays a meaningful role not just in the economy but in how we live our lives.”

    Key Examples and References:

    • India’s success in achieving a 70-year life expectancy with less than 2% budgetary allocation for health.
    • The commitment of ₹1 lakh crore for innovation and technology in the Interim Budget.

    Key Facts:

    • India’s economic growth rate surpassing the global average.
    • Increase in life expectancy from 53 to 70 years in the last four decades.

    Key Data:

    • ₹1 lakh crore corpus for research and technology in the Interim Budget.
    • India’s growth rate compared to the global average.

    Critical Analysis:

    • The article provides an optimistic view of India’s economic growth and achievements.
    • Emphasis on preventive healthcare and innovation aligns with global trends.
    • Challenges include addressing healthcare needs comprehensively and ensuring inclusive growth.

    Way Forward:

    • Sustain economic growth through continued emphasis on innovation and technology.
    • Strengthen preventive healthcare initiatives for comprehensive disease prevention.
    • Address infrastructure challenges for medical value travel to enhance India’s global healthcare appeal.
    • Ensure inclusive growth, managing economic disparities effectively.

  • Early nutrition impacts cognitive development

    Indonesia Accelerates Fight Against Childhood Stunting

    Central Idea:

    Early childhood stunting not only impacts a child’s height but also influences cognitive development, potentially leading to lower educational achievements. The article emphasizes the importance of understanding the underlying mechanisms of this impact, particularly in low- and middle-income countries like India. It discusses a recent study in Ethiopia and Peru, highlighting the negative correlation between stunting at age 5 and later cognitive skills, specifically executive functions. The findings underscore the critical role of early childhood nutrition in determining cognitive development and educational outcomes.

    Key Highlights:

    • Stunting at around age 5 is linked to lower executive functions, including working memory and inhibitory control, in later childhood.
    • Traditional cognitive-achievement tests may not fully capture inherent cognitive skills, and stunting’s impact may extend beyond cognitive deficits to include behavioral factors like delayed school enrollment.
    • The article highlights the need for a deeper understanding of the mechanisms through which stunting affects educational achievements, especially in the context of low- and middle-income countries.

    Key Challenges:

    • Existing research often focuses on specific cognitive-achievement test scores, making it challenging to fully understand the complex relationship between early human capital investments, such as nutrition, and cognitive development.
    • Achieving a comprehensive assessment of cognitive skills is complicated by the interplay of cognitive abilities, educational access, and other behavioral factors.
    • The article stresses the need to move beyond traditional cognitive-achievement tests and focus on a deeper understanding of the mechanisms linking early human capital investments to cognitive development.

    Key Terms and Phrases:

    • Early childhood stunting
    • Cognitive development
    • Executive functions
    • Behavioral factors
    • Household fixed effects
    • Poshan Abhiyaan
    • Integrated Child Development Services
    • Jal Jeevan Mission
    • Swachh Bharat Mission
    • Mother’s Absolute Affection Programme
    • Complementary feeding
    • Anganwadi worker

    Key Quotes:

    • “Stunting at approximately age 5 is negatively related to executive functions measured years later.”
    • “Empirical studies have shown that women’s height and educational attainment are strong predictors of child stunting in India.”
    • “Improvements in sanitation reduce the incidence of diarrhoea and stunting.”
    • “Promoting early breastfeeding, along with continued breastfeeding for two years, is essential for optimal child development.”

    Key Statements:

    • The study in Ethiopia and Peru establishes a negative correlation between stunting at age 5 and later cognitive skills, emphasizing the long-term impact of early childhood stunting.
    • The article stresses the need to move beyond traditional cognitive-achievement tests and focus on a deeper understanding of the mechanisms linking early human capital investments to cognitive development.

    Key Examples and References:

    • Sánchez et al.’s study in ‘World Development’ linking early under-nutrition to executive functions in Ethiopia and Peru.
    • The role of initiatives like Poshan Abhiyaan, Integrated Child Development Services, Jal Jeevan Mission, and Swachh Bharat Mission in addressing stunting in India.

    Key Facts and Data:

    • The study in Ethiopia and Peru provides evidence of the negative relationship between stunting at age 5 and executive functions.
    • Empirical studies highlight the predictive role of women’s height and educational attainment in child stunting in India.

    Critical Analysis:

    The article effectively highlights the limitations of traditional cognitive-achievement tests in assessing the impact of early human capital investments on cognitive development. It emphasizes the need for a more nuanced understanding of the complex factors contributing to lower educational achievements, particularly in low- and middle-income countries. The study’s focus on executive functions and the link between stunting and cognitive skills adds valuable insights to the existing literature.

    Way Forward:

    • Expand initiatives like the Mother’s Absolute Affection Programme to provide comprehensive lactation support and create breastfeeding-friendly environments.
    • Implement and scale up community-based complementary feeding programs to educate parents about the importance of a diverse diet for children.
    • Consider adding an extra Anganwadi worker to each center to enhance preschool instructional time, potentially improving developmental outcomes and creating employment opportunities.

    In summary, addressing child stunting in India requires a multifaceted approach, including comprehensive nutrition initiatives, sanitation improvements, and strategic investments in education and childcare services. The article underscores the need for evidence-based policies to enhance early childhood nutrition and cognitive development.

  • Populism does not help public health

    Centre asks states to create diverse public health cadre | Latest News India - Hindustan Times

    Central Idea:

    The article highlights the need for a shift in the approach to public health management in democratic setups, emphasizing the importance of prioritizing preventive measures over immediate, politically-driven responses. It advocates for a separation of health-care decision-making from short-term political goals to ensure sustainable health strategies that address both immediate and future health needs.

    Key Highlights:

    • Silent victories in preventing diseases often go unnoticed in the pursuit of tangible achievements.
    • Immediate response-focused initiatives divert attention from critical areas like sanitation, disease surveillance, and public health education.
    • The case of dengue exemplifies the prioritization of emergency relief over long-term prevention strategies.
    • The article stresses the importance of evidence-based decision-making and long-term goals in public health policies.
    • Gaps in public health education and the influence of the pharmaceutical industry are recognized challenges.
    • Disparities in achieving health policy targets, especially in nutrition programs, reveal gaps in public health efforts.
    • Socio-economic factors like poverty, sanitation, and overcrowding contribute to health disparities in diseases like tuberculosis.

    Key Terms/Phrases:

    • Preventive health measures
    • Vector bionomics
    • Public health education
    • Pharmaceutical industry influence
    • Socio-economic factors
    • Health policy targets
    • Separation of powers approach

    Key Quotes:

    • “In a democratic setup, leaders often chase tangible achievements and overlook vital preventive efforts.”
    • “Public health decisions should be based on scientific evidence and long-term goals, not electoral cycles.”
    • “Behavioural change is key to managing public health challenges.”
    • “Effective public health management should encompass preventive measures, policy formulation, community health, and environmental health.”

    Key Statements:

    • “Health care will benefit from being separated from political processes.”
    • “Investments in nutrition programs have far-reaching implications for health and productivity.”
    • “Public health is not just about treating diseases but preventing them.”

    Key Examples and References:

    • Dengue as an example of prioritizing immediate relief over long-term prevention.
    • Disparity in achieving targets in the Prime Minister’s Overarching Scheme For Holistic Nourishment (POSHAN) Abhiyan Scheme.
    • Disparity in TB cases between India and the United States due to socio-economic factors.

    Key Facts/Data:

    • 35.5% of children under five were stunted, and 32.1% were underweight in 2019-21.
    • 58.6% to 67.1% increase in prevalence of anaemic children aged 6-59 months.
    • India reported 21.4 lakh TB cases in 2021, an 18% increase from 2020.

    Critical Analysis:

    • The article effectively highlights the drawbacks of immediate, politically-driven health initiatives.
    • Emphasizes the importance of evidence-based decision-making and long-term planning in public health.
    • Recognizes gaps in public health education and the impact of socio-economic factors on health outcomes.

    Way Forward:

    • Advocate for a separation of health-care decision-making from short-term political goals.
    • Strengthen public health education and adopt a multidisciplinary approach.
    • Emphasize evidence-based decision-making and prioritize long-term preventive measures.
    • Address socio-economic factors influencing health outcomes.

  • Health Ministry announces new treatment regimen for Leprosy

    Leprosy

    Introduction

    • The Central government of India has given its approval for a new treatment regimen aimed at hastening the eradication of leprosy in the country.
    • The move, based on the latest global scientific research and endorsed by the World Health Organization (WHO), seeks to transition from a two-drug regimen to a three-drug regimen for Pauci-Bacillary (PB) leprosy cases.

    New Leprosy Treatment Regimen

    • Objective: The primary goal is to halt the transmission of leprosy at the sub-national level by 2027, aligning with the UN’s Sustainable Development Goals, three years ahead of schedule.
    • Transition from Two to Three Drugs: The Ministry of Health and Family Welfare has approved a shift from the existing two-drug regimen for six months to a three-drug regimen for Pauci-Bacillary (PB) cases.
    • Scientific Basis: This decision is grounded in the latest globally accepted scientific research studies and evidence-based practices.
    • WHO Endorsement: The World Health Organization (WHO) has committed to supply the revised drug regimen starting April 1, 2025, signifying international recognition and support for this approach.

    Key Implementation Steps

    • Three-Drug Regimen: The WHO-recommended treatment regimen includes dapsone, rifampicin, and clofazimine, collectively referred to as MDT. MDT is highly effective in killing the pathogen and curing the patient.
    • Advance Requisitions: All States and Union Territories are instructed to submit their requisitions for anti-leprosy drugs a full year in advance to ensure a smooth transition.
    • Unified Implementation Date: The revised classification of leprosy and the treatment regimen for both Pauci-Bacillary (PB) and multi-bacillary (MB) cases in India will come into effect simultaneously on April 1, 2025.

    Understanding Leprosy

    • Leprosy Overview: Leprosy is a chronic infectious disease caused by the Mycobacterium leprae bacteria, primarily affecting the skin and peripheral nerves.
    • Transmission: It spreads through droplets from the nose and mouth during close contact with untreated cases.
    • Curability: Leprosy is curable with multi-drug therapy (MDT).

    Distinction between PB and MB Cases

    • PB Cases: These individuals have fewer visible bacteria and show no signs of advanced disease in biopsies.
    • MB Cases: They have visible bacteria and may exhibit more advanced disease in biopsies.

    Significance of the New Regimen

    • Eradication Target: The adoption of this new treatment regimen is expected to accelerate India’s progress towards leprosy eradication by 2027, reinforcing the country’s commitment to combat this disease.
    • Previous Funding: The WHO has been providing free MDT, initially funded by the Nippon Foundation and later through an agreement with Novartis. This regimen is known as ‘Uniform MDT,’ simplifying administration and manufacturing processes.

  • Re-evaluating the Use of Mosquitofish in India

    Mosquitofish

    Introduction

    • In recent months, several regions in India, including Andhra Pradesh, Odisha, and Punjab, have resorted to releasing mosquitofish into local water bodies as a means to combat mosquito-borne diseases.
    • While this approach aims to address a pressing public health concern, it brings to light ecological challenges associated with the introduction of mosquitofish.

    Understanding Mosquitofish

    • Biological Control of Mosquitoes: Mosquitofish, particularly Gambusia affinis and Gambusia holbrooki, were introduced in freshwater ecosystems in the 1960s as an eco-friendly alternative to chemical pesticides for mosquito control.
    • Widespread Distribution: Originally native to the U.S., these fish have become global inhabitants due to their adaptability and tolerance to environmental fluctuations.
    • Unintended Consequences: Despite good intentions, the proliferation of mosquitofish has led to detrimental ecological and environmental effects.

    Historical Use in India

    • Early Introduction: Gambusia was first introduced in India in 1928 during British rule as a measure to combat malaria.
    • Government and Non-Governmental Involvement: Various governmental organizations, such as the Indian Council of Medical Research (ICMR) and the National Institute of Malaria Research (NIMR), as well as local municipal corporations and health departments, were entrusted with introducing mosquitofish.
    • Widespread Distribution: Gambusia species are now established in multiple habitats across India.

    Ecological Impact

    • Invasive Alien Species: Mosquitofish are among the hundred most detrimental invasive alien species worldwide, leading to the displacement and extinction of native fauna.
    • Threat to Biodiversity: They exhibit voracious feeding habits and aggressive behavior, posing a threat to native fish, amphibians, and freshwater communities.
    • Global Examples: Studies in Australia, New Zealand, and India have shown the harmful consequences of Gambusia presence, including the decline of endemic species and predation on native fish and frogs.

    Sustainable Alternatives

    • WHO Recommendations: The World Health Organization stopped recommending Gambusia as a mosquito control agent in 1982.
    • Government Recognition: In 2018, the National Biodiversity Authority of the Government of India designated G. affinis and G. holbrooki as invasive alien species.
    • Local Solutions: Collaborative efforts between mosquito biologists, entomologists, invasion ecologists, and fish taxonomists can identify native fish species capable of mosquito control.
    • River Basin Approach: Authorities can compile lists of native fish species in each river basin that are effective in controlling mosquito larvae, offering an eco-friendly alternative to invasive species.

    Conclusion

    • The introduction of mosquitofish in India, once intended to combat mosquito-borne diseases, has led to ecological challenges and the disruption of native ecosystems.
    • To mitigate the adverse effects and protect indigenous aquatic biodiversity, it is essential to discontinue the use of Gambusia and instead explore sustainable alternatives rooted in local solutions.
    • By adopting a river basin approach and collaborating across disciplines, India can strike a balance between mosquito control and environmental preservation.

  • ICMR to revisit current National Essential Diagnostics List (NEDL)

    Introduction

    • The Indian Council of Medical Research (ICMR) has initiated the revision of the National Essential Diagnostics List (NEDL), acknowledging the evolving healthcare landscape since its first release in 2019.
    • This move aims to optimize the availability of essential diagnostic tests across all tiers of healthcare facilities in India.

    What is NEDL?

    • Inception: The NEDL extends and builds upon initiatives like the Free Diagnostics Service Initiative (FDI) under which was launched in July 2015 under National Health Mission (NHM).
    • Comprehensive List: The NEDL is designed to cater to all levels of healthcare, including village-level healthcare, primary care, secondary care, and tertiary care facilities.
    • Scope of Tests: The NEDL focuses on diagnostic tests essential for diseases with significant burdens, such as vector-borne diseases (Malaria, Dengue, Filariasis, Chikungunya, Japanese encephalitis), as well as Leptospirosis, Brucellosis, Tuberculosis, Hepatitis (A, B, C, and E), HIV, and Syphilis. Specific tests are marked as desirable, recommended for regions or states with high disease prevalence.
    • In Vitro Diagnostics (IVD): Alongside diagnostic tests, the NEDL recommends corresponding In Vitro Diagnostics (IVD) products, which are tests conducted on samples like blood or tissue taken from the human body.
    • Regulatory Guidance: The NEDL includes a comprehensive guidance document on the “Regulatory framework for diagnostics: National and International.”
    • Human Resources: It also recommends the allocation of human resources, such as ASHA workers, lab technicians, and pathologists, tailored to the proposed list of diagnostics for different healthcare levels.

    Significance of NEDL

    • Quality Assurance: The availability of quality-assured diagnostics enhances the optimal utilization of the Essential Medicine List (EML).
    • SDG Achievement: Implementation of the NEDL contributes to the realization of Sustainable Development Goal (SDG) 3.8, aiming for Universal Health Coverage (UHC).
    • Enhanced Healthcare: The NEDL facilitates evidence-based healthcare, improving patient outcomes, reducing out-of-pocket expenses, and ensuring the effective use of public health facilities. It aids in disease burden assessment, trend analysis, surveillance, outbreak identification, and addressing antimicrobial resistance.
    • Standardization and R&D: The NEDL encourages the standardization of technology and diagnostic services, fostering research and development (R&D) for innovative diagnostics, ultimately leading to cost reduction.

    Revisiting the List: Careful Consideration Process

    • Disease Burden Analysis: The inclusion of diagnostic tests in the NEDL is based on rigorous assessments of disease burden data across India’s diverse states.
    • Alignment with National Programs: Tests align with national health programs to address specific health needs.
    • Adherence to Standards: The NEDL adheres to Indian public health standards and considers the necessary resources, infrastructure, and personnel required at each healthcare facility.

    Factors to Consider

    • Essential Test Criteria: Stakeholders are encouraged to propose tests that meet specific criteria:
      1. Priority for healthcare needs
      2. Alignment with disease prevalence and public health significance
      3. Demonstrated efficacy, accuracy, and cost-effectiveness
    • Impact on Disease Management: Tests should focus on conditions with high disease burdens and substantial public health relevance. The introduction of these tests should significantly enhance disease diagnosis and management.
    • Appropriate Utilization: Any proposed addition to the NEDL must align with the availability of equipment, infrastructure, and qualified personnel, by the Indian Public Health Standards of 2022.

    Conclusion

    • The revision of India’s National Essential Diagnostics List is a crucial step towards ensuring that essential diagnostic tests are accessible at all healthcare levels.
    • By aligning with disease burden data and adhering to stringent criteria, India aims to enhance its public health infrastructure, making diagnostics an integral part of healthcare delivery.
    • The involvement of stakeholders ensures a comprehensive and effective approach to meet the evolving healthcare needs of the nation.

  • Global Surgery: Why access to essential Surgery is important?

    Global Surgery

    Introduction

    • Global surgery, despite its critical importance, often remains in the shadows of global health initiatives.
    • This is particularly evident in South Asia, where the world’s largest population lacking access to essential surgery resides.

    Why discuss this?

    • Global surgery aims to address this disparity by focusing on equitable access to emergency and essential surgical care, encompassing a range of procedures.
    • While 2015 marked a turning point in recognizing the significance of global surgery, this field’s history goes back several decades.

    What is Global Surgery?

    • Equitable Access: Global surgery prioritizes providing equitable access to emergency and essential surgical care, predominantly in low- and middle-income countries (LMICs), but also in under-served populations within high-income countries (HICs).
    • Scope of Surgery: It encompasses essential and emergency surgeries, including surgery, obstetrics, trauma, and anaesthesia (SOTA).

    Emergence of Global Surgery

    • Annus Mirabilis of 2015: This year marked a pivotal moment in recognizing the global significance of surgical care.
    • Influential Reports: The Disease Control Priorities Network (DCPN) report sponsored by the World Bank and The Lancet Commission on Global Surgery (LCoGS) played key roles.
    • WHO Resolution 68.15: The World Health Organization Declaration on Safe Surgery highlighted the essential role of surgical systems in achieving universal health coverage.

    Magnitude of the Problem

    • Access Disparities: Over 70% of the global population, around five billion people, lack timely access to safe and affordable surgical care.
    • Regional Disparities: Access gaps are most severe in low- and lower-middle-income countries (LLMICs), with 99% and 96% of people facing disparities, compared to 24% in HICs.
    • South Asia’s Challenge: Over 1.6 billion people, over 98% of South Asia’s population, lack access to safe and affordable SOTA care.
    • Disease Burden: In 2010, surgically treatable conditions caused around 17 million deaths, surpassing the combined mortality burden of HIV/AIDS, tuberculosis, and malaria.
    • Economic Impact: The cumulative projected loss to global GDP due to insufficient surgical care could reach $20.7 trillion by 2030.

    Current Efforts and Neglect

    • Neglect in Policies: Surgical care often receives little attention in international and national policies.
    • Limited Research Focus: Research in global surgery is underrepresented compared to global health.
    • Funding Neglect: Funding for surgery is significantly lower than for other health sectors.
    • Research Funding Disparity: Research funding for surgery-related projects is scarce compared to other health fields.

    Way Forward

    • Cost-Effectiveness: Global surgery has demonstrated that emergency and essential surgical care is cost-effective and cost-beneficial.
    • Policy Commitment: Many countries have initiated National Surgical, Obstetrics, and Anaesthesia Plans (NSOAPs), demonstrating political and policy commitment.
    • Positive Initiatives: Several South Asian countries have launched initiatives to expand surgical access.
    • Research and Innovation: Prioritizing research, policy support, and sustainable financing are key to addressing global surgery challenges.

  • Kerala’s Operation AMRITH to combat Antimicrobial Resistance

    Introduction

    • The Kerala Drug Control Department launched Operation Amrith (Antimicrobial Resistance Intervention For Total Health), a significant initiative to curb the overuse of antibiotics in the state.

    Operation AMRITH

    • Objective: The initiative aims to optimize antibiotic use by preventing over-the-counter (OTC) sales and ensuring compliance with prescription requirements.
    • Pharmacy Regulations: Pharmacies are required to maintain accurate records of antibiotic sales and display notices stating that antibiotics will not be sold without a doctor’s prescription.
    • Public Participation: The initiative encourages public involvement by allowing individuals to report pharmacies that sell antibiotics without a prescription.

    Enforcement and Compliance

    • Surprise Raids: The program includes conducting surprise checks in retail medical shops to detect OTC sales of antibiotics.
    • Toll-Free Complaint Number: A toll-free number (18004253182) is provided for the public to lodge complaints against medical shops violating the rules.
    • Immediate Action: Complaints are swiftly transferred to relevant zonal offices for verification, followed by immediate departmental action upon confirmation of violations.

    Background and Context

    • Kerala’s AMR Strategy: Kerala was the first state in India to develop a state action plan on AMR, the Kerala Anti-Microbial Resistance Strategic Action Plan (KARSAP), in 2018.
    • Multi-Sectoral Approach: The plan, aligned with India’s National Action Plan on AMR, addresses human, animal, and environmental aspects of AMR containment.
    • Support and Collaboration: The plan was developed with contributions from the Centre for Science and Environment and involves various state departments in its implementation.
    • Surveillance Networks: The Kerala Antimicrobial Resistance Surveillance Network (KARS-NET) monitors AMR in humans, while an integrated plan covers non-human sector surveillance.
    • AMR Laboratory: The Kerala State Pollution Control Board (KSPCB) inaugurated an AMR laboratory for environmental surveillance in August 2023.
    • PROUD Initiative: The Programme on Removal of Unused Drugs (PROUD) is a drug take-back program piloted in Thiruvananthapuram for the proper disposal of unused antibiotics.

  • Are antibiotics over-prescribed in India?

    Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure | Humanities and Social Sciences Communications

    Central Idea:

    The National Centre for Disease Control (NCDC) conducted a study revealing that over half of the surveyed hospital patients in India were given antibiotics preventively rather than for treatment. This overuse of antibiotics poses a significant risk as India already faces a high burden of drug-resistant pathogens, contributing to antimicrobial resistance (AMR). Experts Sumit Ray and Abdul Ghafur discuss the causes, consequences, and potential solutions to this issue, emphasizing the need for judicious antibiotic use and addressing systemic challenges.

    Key Highlights:

    • Antimicrobial Resistance (AMR): AMR refers to microorganisms becoming resistant to antibiotics. India is grappling with high levels of drug-resistant bacteria, impacting patient outcomes negatively.
    • Factors Leading to AMR: Inappropriate antibiotic use, lack of rapid diagnostics, insufficient training, inadequate monitoring, and pharmaceutical industry incentives contribute to the rise of AMR.
    • NCDC Survey Findings: The survey showed that 55% of patients received antibiotics as a preventive measure, indicating a potential over-prescription issue.
    • Root Causes of Over-Prescription: Overcrowded hospitals, limited access to rapid diagnostics, and economic factors drive doctors to opt for antibiotics as a quicker and cheaper alternative.
    • Immediate Threat: The immediate danger is evident in the survey’s findings, with a significant percentage of patients exhibiting resistance to various generations of antibiotics, leading to poor health outcomes.
    • AMR as a Complex Challenge: AMR is not solely a medical issue but a complex challenge involving socio-economic, political, and infrastructural factors.

    Key Challenges:

    • Over-Prescription: Doctors tend to prescribe antibiotics unnecessarily due to factors like overcrowded hospitals, limited time for examinations, and inadequate diagnostic facilities.
    • Lack of Rapid Diagnostics: The absence of quick and affordable diagnostic tools contributes to the inappropriate use of antibiotics.
    • Systemic Issues: Weak governance, inadequate sanitation, poverty, and limited access to clean water are interconnected factors contributing to AMR.
    • Implementation Gap: Existing guidelines for antibiotic use exist, but there is a gap in their implementation, leading to over-prescription.
    • Incentivization in Pharma Industry: The pharmaceutical industry’s encouragement of certain prescribing practices exacerbates the problem.

    Key Terms/Phrases:

    • Antimicrobial Resistance (AMR): Microorganisms becoming resistant to antibiotics.
    • Over-the-Counter Antibiotics: Antibiotics available without a prescription.
    • H1 Rule: Regulation prohibiting certain antibiotics without a prescription.
    • Colistin: A potent antibiotic, banned for growth promotion in poultry farming.
    • Third/Fourth-Generation Antibiotics: Antibiotics of advanced generations, facing resistance in bacterial strains.

    Key Quotes:

    • “I treat infections in cancer patients, who are the most immuno-compromised patients you can come across. Patients are losing their lives because of AMR.” – Abdul Ghafur
    • “What is essential is the linking of labs to all levels of clinical setups and the fast transmission of infection-related data between the lab and the clinician.” – Sumit Ray

    Key Examples and References:

    • National Centre for Disease Control (NCDC) survey on antibiotic use in Indian hospitals.
    • Indian government’s 2019 ban on colistin use in poultry farming.

    Critical Analysis:

    • Overcrowded hospitals and limited diagnostic access drive over-prescription.
    • Addressing AMR requires a holistic approach, considering socio-economic factors.

    Way Forward:

    • Restrict access to reserve antibiotics to reduce resistance.
    • Improve public health systems, delivery, and sanitation to curb AMR.
    • Enforce existing laws, such as the ban on over-the-counter antibiotic sales.

    In conclusion, addressing the overuse of antibiotics in India requires a multifaceted approach, involving improvements in healthcare infrastructure, diagnostic capabilities, and enforcement of regulations. The goal is to mitigate the immediate threat of AMR and ensure the judicious use of antibiotics for effective treatment.